Efficacy and safety of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus

Medicine and Dentistry

• Antidiabetic Agent 33%
• Cell Function 33%
• Cells 33%
• Combination Therapy 33%
• Development 33%
• Diseases 33%
• Glucose 33%
• Glucosuria 33%
• Glucotoxicity 33%
• Glycemic Control 100%
• Hyperglycemia 33%
• Hypoglycemia 66%
• Incidence 33%
• Insulin 33%
• Maturity Onset Diabetes of the Young 100%
• Mechanism of Action 66%
• Microvascular Complication 66%
• Oral Antidiabetic Agent 33%
• Pathogenesis 33%
• Plasma 33%
• Side Effect 33%
• Sodium Glucose Cotransporter 33%
• Sodium Glucose Cotransporter 2 Inhibitor 33%
• Therapeutic Agent 33%
• Therapeutic Procedure 33%
• Tissues 33%
• Weight Loss 33%